Advanced non-small cell lung cancer therapy: historical and future perspectives

By Reck M.  

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 135-147

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Integration of targeted therapy in the management of locally advanced, unresectable non-small-cell lung cancer

By Lo Ernest   Daly Megan E   Mack Philip C   Kelly Karen   Lara Jr Primo N  

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 75-85

Future Medicine

Access to resources Recommend Favorite

Clinical evaluation of targeted arterial perfusion of verapamil and chemotherapeutic drugs in interventional therapy of advanced lung cancer

By Huang Jin   Zhang Tengyue   Ma Kelong   Fan Pingsheng   Liu Yabei   Weng Chengtao   Fan Gaofei   Duan Qiaohong   Zhu Xianhai  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 889-896

Springer Publishing Company

Access to resources Recommend Favorite

ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer

By                        

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 811-815

Spandidos Publications

Access to resources Recommend Favorite